Alexandre Bretel In the common imaginary, genetic modifications belong above all to the field of science fiction. But some techniques have already been in use for several decades, and new ones raise unprecedented ethical questions. The CRISPR-Cas9 technique thus allows very precise modifications to be made to the genome, which […]
YEBN
18 posts
Last Thursday was the last seminar of the Career Development Programme “Bio-Building yourself” organized by YEBN. The idea of this programme arised from the need of giving our members and scientific audience in general the opportunity to keep growing professionaly and learning how to develop their personal industrial pathway during […]
Dear community, Here it comes, the 2nd Newsletter of 2020 and… Yes! We are glad to announce to you that our new European Executive Board (EB) 2020/2021 has again the maximum size of 7 team members, integrating three new talents and covering 6 nations – France, Germany, Italy, Poland, Spain […]
In this programme, focused on how to develop your personal industrial pathway, we will be joined by three professionals from the bio-field. Thanks to the speakers, you will be able to analyse your strengths, weaknesses and opportunities to develop your own plan to succeed in your career! You will learn […]
The 25th of April the YEBN held its first online Delegate Assembly with great success! In this assembly, we discussed the general pathway and future of the YEBN, we were joined by ANBiotec, Nouvelle Génération des Biotechnologistes and AYB, and overall had a really enriching experience.We elected the new Executive […]
FÉDÉEH is a French nonprofit student federation for the empowerment of dynamic students and young professionals with disabilities and students’ associations promoting inclusive campus and society. The mission of FEDEEH is to optimize, through a long-term commitment, the study conditions and professional inclusion for young people with impairments and disabilities […]
Brief Introduction about yourself and the project (TATAMI) I am a scientific researcher looking for new therapeutic approaches for neuromuscular diseases. In this project particularly we are developing a novel therapeutic strategy for myotonic dystrophy based on blocking specific small RNAs or microRNA with antisense oligonucleotides, or anti-miRs. Tell us […]
Brief Introduction about yourself and ARTHEx Biotech I have been working as a postdoctoral researcher in the department of Genetics in the University of Valencia, dedicated mainly to deciphering the pathomechanisms of Myotonic Dystrophy disease and finding new therapeutic targets for the disease. ARTHEx Biotech S.L is a spin-off company […]
The UN has launched a project, the Sustainable Development Goals (or SDGs), in order to “achieve a better and more sustainable future for all”. They are a blueprint, a map for the future for governments, companies, individuals and associations like the YEBN for a better future for all. They focus […]
Representation of the YEBN in the Netherlands: Networking towards an enhanced #Biotech future! Ismael Ávila, YEBN President, and Alexandre Bretel, YEBN Networking Task Group leader joined the #ENABLE initiative for #Young #Researchers! Here in the YEBN we encourage participation and involvement across associations as a way of strengthening each other […]
New Partner Announcement! Coming from the Netherlands, one of the biggest biotech clusters of Europe, Health Valley Netherlands! Health Valley Netherlands is the biggest Life Sciences & Health innovation network in the Netherlands. The network unites companies, care organisations, knowledge institutes and authorities, and enables them to grow stronger together. […]